Metabolic Control in Anesthesia and Surgery
MACS
Deteriorated Metabolic Control in the Perioperative Period in Surgical Patients: What is the Impact of Anesthetic Preparation and Patient Frailty?
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this observational study is to investigate how a standard dose of the drug dexamethasone affects blood sugar levels during and after non-cardiac surgery in adult patients. The main questions it aims to answer are:
- How does dexamethasone influence blood sugar levels in patients undergoing non-cardiac surgery?
- Does continuous glucose monitoring (CGM) provide a more accurate estimate of blood sugar fluctuations compared to traditional time-specific finger-prick measurements? Participants are scheduled to receive dexamethasone as part of standard anesthesia care and will undergo their planned surgery. As part of the study, a continuous glucose monitoring (CGM) device will be placed on their upper arm approximately 12 hours before surgery and will remain in place for up to 10 days after the operation. During this period, their blood sugar levels will be measured using both the CGM device and traditional finger-prick tests. CGM readings are blinded for both participants and clinicians. No additional treatments or changes to their standard care will be made as a result of their participation in the study. The study will include 100 adult patients from the Department of Anesthesiology at Sjællands University Hospital, Roskilde.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 23, 2026
CompletedFirst Submitted
Initial submission to the registry
April 27, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
May 7, 2026
April 1, 2026
2.2 years
April 27, 2026
May 4, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Characterization of hyperglycemia I
Peak glucose level
Up to 10 days postoperatively
Characterization of hyperglycemia II
Duration of hyperglycemia
Up to 10 days postoperatively
Secondary Outcomes (2)
Correlation between pre- and postoperative glucose trajectories
Up to 10 days postoperatively
Subgroup analyses
Up to 10 days postoperatively
Eligibility Criteria
Adult, surgical population where dexamethasone may be administered as part of anesthetic preparation of the patient for surgery.
You may qualify if:
- Adult patients (≥18 years) scheduled for elective non cardiac surgery
- Expected surgery duration \>1 hour
- Administration of dexamethasone as part of standard anaesthetic regimen or planned by the responsible anaesthetist to enhance recovery or to limit risk of PONV.
- Ability to provide written informed consent
You may not qualify if:
- Not possible to obtain consent or permission
- Known allergy or adverse reaction to dexamethasone
- Type 1 diabetes (due to need for insulin titration)
- Active infection, sepsis, or immunosuppression
- Contraindications to continuous glucose monitoring (CGM)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zealand University Hospital
Roskilde, 4000, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Anne M Brinck, Msc Medicine
Zealand University Hospital, Roskilde, Denmark
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2026
First Posted
May 7, 2026
Study Start
April 23, 2026
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
May 7, 2026
Record last verified: 2026-04